Boston Scientific Corporation Statistics
Share Statistics
Boston Scientific Corporation has 1.47B shares outstanding. The number of shares has increased by 0.46% in one year.
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.47B |
| Failed to Deliver (FTD) Shares | 6.58K |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 12.33M, so 0.84% of the outstanding shares have been sold short.
| Short Interest | 12.33M |
| Short % of Shares Out | 0.84% |
| Short % of Float | 0.84% |
| Short Ratio (days to cover) | 2.51 |
Valuation Ratios
The PE ratio is 52.73 and the forward PE ratio is 31.8. Boston Scientific Corporation's PEG ratio is 0.36.
| PE Ratio | 52.73 |
| Forward PE | 31.8 |
| PS Ratio | 5.9 |
| Forward PS | 6.8 |
| PB Ratio | 4.36 |
| P/FCF Ratio | 49.32 |
| PEG Ratio | 0.36 |
Enterprise Valuation
Boston Scientific Corporation has an Enterprise Value (EV) of 92.62B.
| EV / Earnings | 58.14 |
| EV / Sales | 6.5 |
| EV / EBITDA | 26.82 |
| EV / EBIT | 39.53 |
| EV / FCF | 54.39 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.32 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.47 |
| Total Debt / Capitalization | 32.06 |
| Cash Flow / Debt | 0.28 |
| Interest Coverage | 8.84 |
Financial Efficiency
Return on equity (ROE) is 0.08% and return on capital (ROIC) is 6.47%.
| Return on Equity (ROE) | 0.08% |
| Return on Assets (ROA) | 0.05% |
| Return on Capital (ROIC) | 6.47% |
| Revenue Per Employee | 296.67K |
| Profits Per Employee | 33.19K |
| Employee Count | 48.00K |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.75 |
Taxes
| Income Tax | 393.00M |
| Effective Tax Rate | 0.2 |
Stock Price Statistics
The stock price has increased by 56.11% in the last 52 weeks. The beta is 0.8, so Boston Scientific Corporation's price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | 56.11% |
| 50-Day Moving Average | 88.78 |
| 200-Day Moving Average | 79.85 |
| Relative Strength Index (RSI) | 58.26 |
| Average Volume (20 Days) | 5.71M |
Income Statement
In the last 12 months, Boston Scientific Corporation had revenue of 14.24B and earned 1.59B in profits. Earnings per share was 1.08.
| Revenue | 14.24B |
| Gross Profit | 9.89B |
| Operating Income | 2.34B |
| Net Income | 1.59B |
| EBITDA | 3.45B |
| EBIT | 2.34B |
| Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 865.00M in cash and 9.49B in debt, giving a net cash position of -8.63B.
| Cash & Cash Equivalents | 865.00M |
| Total Debt | 9.49B |
| Net Cash | -8.63B |
| Retained Earnings | 819.00M |
| Total Assets | 38.08B |
| Working Capital | 2.85B |
Cash Flow
In the last 12 months, operating cash flow was 2.50B and capital expenditures -800.00M, giving a free cash flow of 1.70B.
| Operating Cash Flow | 2.50B |
| Capital Expenditures | -800.00M |
| Free Cash Flow | 1.70B |
| FCF Per Share | 1.17 |
Margins
Gross margin is 6.95K%, with operating and profit margins of 1.65K% and 1.12K%.
| Gross Margin | 6.95K% |
| Operating Margin | 1.65K% |
| Pretax Margin | 1.39K% |
| Profit Margin | 1.12K% |
| EBITDA Margin | 24.25% |
| EBIT Margin | 16.45% |
| FCF Margin | 11.96% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.18% |
| FCF Yield | 1.27% |
Analyst Forecast
The average price target for BSX is $100, which is 9.6% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $100 |
| Price Target Difference | 9.6% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 23 |
Stock Splits
The last stock split was on Nov 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 5.51 |
| Piotroski F-Score | 7 |